Anidulafungin

Active ingredient description

Anidulafungin is a semi-synthetic echinocandin, a lipopeptide synthesised from a fermentation product of Aspergillus nidulans. Anidulafungin selectively inhibits 1,3-β-D glucan synthase, an enzyme present in fungal, but not mammalian cells.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Anidulafungin
J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX06

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
Structured Product Labeling (SPL/PLR)
US

Medicines

Anidulafungin is the active ingredient of these drugs:

Drug
Countries

Turkey

Turkey

South Africa

Turkey

Turkey

Austria Brazil Cyprus Ecuador Estonia

Mexico

Canada Hong Kong Singapore South Africa United States

Turkey

Turkey

Turkey

Turkey

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₅₈H₇₃N₇O₁₇
Molecular mass: 1,140.237 g/mol

External identifiers

CAS Substance: 166663-25-8
DrugBank Drug: DB00362
KEGG Drug: D03211
PubChem Compound: 166548
RxNorm Ingredient: 341018
SNOMED-CT Concept: 422157006
Anidulafungin (substance)
UNII Identifier: 9HLM53094I
ANIDULAFUNGIN